Inhibition of MEK with AZD6244 is cytostatic as a monotherapy in melanoma, but cytotoxic when combined with docetaxel leading to tumour regression in vitro and in vivo

Haass, Nikolas K., Sproesser, Katrin, Nguyen, Thiennga K., Contractor, Rooha, Herlyn, Meenhard and Smalley, Keiran S. M. (2009). Inhibition of MEK with AZD6244 is cytostatic as a monotherapy in melanoma, but cytotoxic when combined with docetaxel leading to tumour regression in vitro and in vivo. In: Journal of Investigative Dermatology. 5th Annual Scientific Meeting of the Australasian-Society-for-Dermatology-Research, Sydney Australia, (2913-2913). May 21-22, 2008.

Author Haass, Nikolas K.
Sproesser, Katrin
Nguyen, Thiennga K.
Contractor, Rooha
Herlyn, Meenhard
Smalley, Keiran S. M.
Title of paper Inhibition of MEK with AZD6244 is cytostatic as a monotherapy in melanoma, but cytotoxic when combined with docetaxel leading to tumour regression in vitro and in vivo
Conference name 5th Annual Scientific Meeting of the Australasian-Society-for-Dermatology-Research
Conference location Sydney Australia
Conference dates May 21-22, 2008
Proceedings title Journal of Investigative Dermatology   Check publisher's open access policy
Publication Year 2009
Sub-type Published abstract
ISSN 0022-202X
Volume 129
Issue 12
Start page 2913
End page 2913
Total pages 1
Language eng
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Conference Paper
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Fri, 30 Oct 2015, 19:21:17 EST by System User